• EPPICon 2018
  • FACTS
  • EVENTS
  • SPONSORS & PARTNERS
  • ABOUT
  • MANAGEMENT
  • CONTACT

Winning Against Odds: Crossing Barriers in Drug Delivery Area

1999June 11, 2018leena

When: January 28, 1999

“Winning Against Odds: Crossing Barriers in Drug Delivery Area”

Dr Dinesh Patel
Founder and CEO / President, Theratech Inc.

Previous post The Importance of Technology, Management, Markets (and Serendipity)

PAST EVENTS

  • Categories
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
    • 1998
    • Privacy Policy

    © Copyrights 2018 Eppic Global All Rights Reserved

    Designed By Bolas Intelli Solution

    Krishna V. Shenoy

    Krishna V. Shenoy, PhD, is the Hong Seh and Vivian W. M. Lim Professor of Engineering. He is with the Departments of Electrical Engineering and by courtesy, Bioengineering and Neurobiology at Stanford University. He is also a Howard Hughes Medical Institute Investigator. Prof. Shenoy holds a BS in Electrical and Computer Engineering from UC Irvine (1987-1990), a PhD in Electrical Engineering and Computer Science from MIT (1990-1995), was a postdoctoral fellow in Neurobiology at Caltech (1995-2001), and has been on faculty at Stanford since then (Assistant Prof. 2001-2008, Associate Prof. 2008-2012, Full Prof. 2012-2017, Endowed Chair 2017 to present). Prof. Shenoy directs the Stanford Neural Prosthetic Systems Lab (basic neuroscience and engineering) and co-directs the Stanford Neural Prosthetics Translational Laboratory (clinical trials), which aim to help restore lost motor function to people with paralysis. Honors and awards include a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, a Sloan Fellow, a McKnight Technological Innovations in Neurosciences Award, an NIH Director’s Pioneer Award, the 2010 Stanford University Postdoc Mentoring Award, and he was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Prof. Shenoy serves on the Scientific Advisory Boards of The University of Washington’s Center for Sensorimotor Neural Engineering (a National Science Foundation Engineering Research Center), CTRL-Labs Inc., MIND-X Inc., Inscopix Inc. and Heal Inc. He is also a consultant for Neuralink Corp.

    Submit Your Pitch

    OR

    Email your pitch to ramani@shasta-bioventures.com

    EPPICon 2018: Speed Pitch Session

    Speed Pitch: Entrepreneurs in Healthcare and Life sciences pitch their ideas to seasoned investors – a unique opportunity for symbiosis of ideas and investments

    What is the Need for Speed Session
    This is a fabulous opportunity for start-ups get on stage and make a five-minute pitch to a distinguished panel of top-notch VC’s and biotech executives. Multiple entrepreneurs of early stage companies in the life-sciences can talk about their idea, technology, market, etc., get quick feedback from the VC panel and get exposure to various potential collaborators / partners.

    Why present at the Speed Pitch Session
    This conference attracts more than 200 professionals in the healthcare / life science industry. Our members are distributed across therapeutics, informatics, devices, and diagnostics – the ideal audience for early stage companies.

    What’s in it for Entrepreneurs

    • Attract investors, advisors, mentors
    • Attract business, technical partners
    • Get constructive feedback and potential reinforcement of technology

    What do you need to do in five minutes
    You have just five minutes so please focus on the most important aspects of your company or technology.

    • Product opportunity and market potential
    • State of the company, management team, development timelines and key milestones
    • Key differentiating factors from existing products and how they meet market need
    • What is the entrepreneur looking for – specifically clearly articulate funding goals, use of proceeds and potential milestones achieved with this funding

    Format: 4-5 VCs. One startup every 5 minutes. Previous firms represented at the event were Soffinova, NewLeaf, Artiman, VIVO, Orbimed…

    Please email a presentation to ramani@shasta-bioventures.com by September 14, 2018, to be considered for selection. Shortlisted candidates will be notified by September 18, 2018.

    Please enter your details below to register.